Myotonia - 29 Studies Found

Completed : Efficacy and Safety of DHEA for Myotonic Dystrophy
: Myotonic Dystrophy
: 2005-09-10
: Drug: dehydroepiandrosterone 100 and 400 mg
Completed : Clinical Efficacy Trial of Mexiletine for Myotonic Dystrophy Type 1
: Myotonic Dystrophy
: 2011-07-20
:
  • Drug: Mexiletine 150 mg/kg Mex
Recruiting : Ventilatory Response After Non Invasive Ventilation in Type 1 Myotonic Dystrophy
:
  • Myotonic Dystrophy 1
  • Steinert Dise
    : 2016-08-12
    : Device: Non Invasive Ventilation. Non Invasive Mechanical Ventilation through oronasal mask. Mode: Bilev
Recruiting : PhenoDM1 (Myotonic Dystrophy Type 1 Natural History Study)
: Myotonic Dystrophy Type 1
: 2016-03-22
Completed : Tracking the Brain in Myotonic Dystrophies: a 5-year Longitudinal Follow-up Study
:
  • Myotonic Dystrophy 1
  • Myotonic Dystrophy : 2016-03-23
    :
    • Other: medical history The com
Active, not recruiting : Observational Prolonged Trial in Myotonic Dystrophy Type 1
: Myotonic Dystrophy Type 1
: 2014-04-11
: Behavioral: Behavioural change intervention The intervention is cognitive behaviour therapy (CBT). The C
Recruiting : Sleep Breathing Disorders, a Main Trigger for Cardiac ARythmias in Type I Myotonic Dystrophy ?
: Myotonic Dystrophy
: 2015-02-03
Completed : Methylphenidate in Myotonic Dystrophy Type 1
: Dystrophia Myotonica 1
: 2011-06-01
:
  • Drug: Methylphenidate One Tabl
Completed : A Safety andTolerability Study of Multiple Doses of ISIS-DMPKRx in Adults With Myotonic Dystrophy Type 1
: Myotonic Dystrophy Type 1
: 2014-12-04
:
  • Drug: IONIS-DMPKRx Drug

Completed : Effects of SomatoKine (Iplex)Recombinant Human Insulin-like Growth Factor-1/Recombinant Human Insulin-like Growth Factor-binding Protein-3 (rhIGF-I/rhIGFBP-3) in Myotonic Dystrophy Type 1 (DM1)
: Myotonic Dystrophy
: 2005-10-03
: Drug: SomatoKine/IPLEX Cohort 1: self-administered subcute
<<< Previous | Next >>>